Эпкоритамаб
EpcoritamabМНН
Rec. INN (наименование, зарегистрированное ВОЗ)
АТХ
Фармакологическая группа
Категория при беременности по FDA
N (не классифицировано FDA)
CAS
2134641-34-0
Химическое название
immunoglobulin G1-lambda/kappa, anti-[Homo sapiens CD3E (CD3 epsilon)] and anti-[Homo sapiens MS4A1 (membrane-spanning 4-domains subfamily A member 1, CD20)], monoclonal bispecific antibody;
gamma1 heavy chain chimeric anti-CD3E (1-454) [VH (Mus musculus IGHV10-1*02 (93.9%) -(IGHD) -IGHJ3*01 (93.3%)/Homo sapiens IGHV3-72*01 (81.0%) -(IGHD) -IGHJ6*01 (67.0%)) [8.10.16] (1-125) -Homo sapiens IGHG1*03 G1m3, nG1m1 (CH1 R120 (222) (126-223), hinge 1-15 (224-238), CH2 L1.3>F (242), L1.2>E (243), D27>A (273) (239-348), CH3 E12 (364), M14(366), F85.1>L (413) (349-453), CHS K2>del (454)) (126-454)], (228-214')-disulfide with lambda light chain chimeric (1'-215') [V-LAMBDA (Mus musculus IGLV1*01 (83.3%) -IGLJ1*01 (100%)/Homo sapiens IGLV8-61*01 (70.8%) - IGLJ3*02 (100%)) [9.3.9] (1'-109') -Homo sapiens IGLC2*01 (100%) (110'-215')];
gamma1 heavy chain Homo sapiens anti-MS4A1 (1''-451'') [VH (Homo sapiens IGHV3-9*01 (96.0%) -(IGHD) -IGHJ6*01 (100%)) [8.8.15] (1''-122'') -Homo sapiens IGHG1*03 G1m3, G1m1 (CH1 R120 (219) (123-220), hinge 1-15 (221-235), CH2 L1.3>F (239), L1.2>E (240), D27>A (270) (236-345), CH3 E12 (361), M14 (363), K88>R (414) (346-450), CHS K2>del (451)) (123''-451'')], (225''-214''')-disulfide with kappa light chain Homo sapiens (1'''-214''') [V-KAPPA (Homo sapiens IGKV3-11*01 (100%) -IGKJ5*01 (100%)) [6.3.9] (1'''-107''') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'''-214''')]; dimer (234-231'':237-234'')-bisdisulfide, produced in Chinese Hamster Ovary (CHO) cell line, glycoform alfa
gamma1 heavy chain chimeric anti-CD3E (1-454) [VH (Mus musculus IGHV10-1*02 (93.9%) -(IGHD) -IGHJ3*01 (93.3%)/Homo sapiens IGHV3-72*01 (81.0%) -(IGHD) -IGHJ6*01 (67.0%)) [8.10.16] (1-125) -Homo sapiens IGHG1*03 G1m3, nG1m1 (CH1 R120 (222) (126-223), hinge 1-15 (224-238), CH2 L1.3>F (242), L1.2>E (243), D27>A (273) (239-348), CH3 E12 (364), M14(366), F85.1>L (413) (349-453), CHS K2>del (454)) (126-454)], (228-214')-disulfide with lambda light chain chimeric (1'-215') [V-LAMBDA (Mus musculus IGLV1*01 (83.3%) -IGLJ1*01 (100%)/Homo sapiens IGLV8-61*01 (70.8%) - IGLJ3*02 (100%)) [9.3.9] (1'-109') -Homo sapiens IGLC2*01 (100%) (110'-215')];
gamma1 heavy chain Homo sapiens anti-MS4A1 (1''-451'') [VH (Homo sapiens IGHV3-9*01 (96.0%) -(IGHD) -IGHJ6*01 (100%)) [8.8.15] (1''-122'') -Homo sapiens IGHG1*03 G1m3, G1m1 (CH1 R120 (219) (123-220), hinge 1-15 (221-235), CH2 L1.3>F (239), L1.2>E (240), D27>A (270) (236-345), CH3 E12 (361), M14 (363), K88>R (414) (346-450), CHS K2>del (451)) (123''-451'')], (225''-214''')-disulfide with kappa light chain Homo sapiens (1'''-214''') [V-KAPPA (Homo sapiens IGKV3-11*01 (100%) -IGKJ5*01 (100%)) [6.3.9] (1'''-107''') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'''-214''')]; dimer (234-231'':237-234'')-bisdisulfide, produced in Chinese Hamster Ovary (CHO) cell line, glycoform alfa
Структура
Иностранные названия
- Epcoritamabum (латинское)
- Epcoritamab (английское)
- Epcoritamab (немецкое)
- Épcoritamab (французское)
- Epcoritamab (испанское)
Подробнее по теме
Узнайте дополнительные сведения о действующем веществе Эпкоритамаб: